APA (7th ed.) Citation

Asaumi, R., Nunoya, K., Yamaura, Y., Taskar, K. S., & Sugiyama, Y. (2022). Robust physiologically based pharmacokinetic model of rifampicin for predicting drug–drug interactions via P‐glycoprotein induction and inhibition in the intestine, liver, and kidney. CPT: Pharmacometrics & Systems Pharmacology, 11(7), 919. https://doi.org/10.1002/psp4.12807

Chicago Style (17th ed.) Citation

Asaumi, Ryuta, Ken‐ichi Nunoya, Yoshiyuki Yamaura, Kunal S. Taskar, and Yuichi Sugiyama. "Robust Physiologically Based Pharmacokinetic Model of Rifampicin for Predicting Drug–drug Interactions via P‐glycoprotein Induction and Inhibition in the Intestine, Liver, and Kidney." CPT: Pharmacometrics & Systems Pharmacology 11, no. 7 (2022): 919. https://doi.org/10.1002/psp4.12807.

MLA (9th ed.) Citation

Asaumi, Ryuta, et al. "Robust Physiologically Based Pharmacokinetic Model of Rifampicin for Predicting Drug–drug Interactions via P‐glycoprotein Induction and Inhibition in the Intestine, Liver, and Kidney." CPT: Pharmacometrics & Systems Pharmacology, vol. 11, no. 7, 2022, p. 919, https://doi.org/10.1002/psp4.12807.